News Quantified

TRVN – trevena, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

Trevena, Inc. (NASDAQ: TRVN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.

5.9%

MISS

-18.6%

BEAT

Form DEFR14A TREVENA INC

Form DEF 14A TREVENA INC For: Jun 13

Form 8-K TREVENA INC For: Apr 19

Form PRE 14A TREVENA INC For: Jun 13

Form 8-K TREVENA INC For: Apr 05

Top News Gainers

3/4 Form 8-K TREVENA INC For: Mar 03 15.7%

4/13 Form DEF 14A TREVENA INC For: May 13 9.5%

9/6 Form 8-K TREVENA INC For: Sep 03 8.6%

12/12 Trevena Presents Phase 1 Data on TRV250 for Acute Migraine at American College of Neuropsychopharmacology 2019 Annual Meeting 6.3%

12/4 Form 4 TREVENA INC For: Dec 02 Filed by: Bourdow Carrie L. 6.0%

4/23 Trevena Announces Publication of Comprehensive Review of Oliceridine Data 5.5%

5/10 Q1/2019 3/31/2019 EPS -0.060 ZacksConsensus -0.090 ActVsEst 0.030 - Beat 3.3%

6/27 Trevena Appoints Barry Shin as Chief Financial Officer 3.0%

3/13 Form 8-K TREVENA INC For: Mar 12 2.8%

10/11 Trevena Inc (NASDAQ: TRVN) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $1.00 price target on the stock. 2.6%

Top News Decliners

11/4 Form 10-Q TREVENA INC For: Sep 30 -21.9%

3/5 Form 8-K TREVENA INC For: Mar 04 -15.4%

6/24 Trevena Announces Publication of APOLLO-2 Results in Pain Practice -11.3%

11/16 Trevena Inc (NASDAQ: TRVN) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -10.5%

7/19 TREVENA INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Trevena, Inc. - TRVN -9.5%

3/5 Trevena to Report Fourth Quarter and Full Year 2019 Results on March 12, 2020 -8.3%

2/10 Form 8-K TREVENA INC For: Feb 07 -8.2%

6/20 Trevena Announces Initiation of Healthy Volunteer Study for Oliceridine -7.1%

3/14 Trevena Inc (NASDAQ: TRVN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.50 price target on the stock. -6.3%

4/1 Form PRE 14A TREVENA INC For: May 13 -5.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day